Background/Aims: Cross-classification analyses are rarely reported. We investigated the prognostic factors for chronic kidney disease (CKD) progression using a body mass index (BMI)-based cross-classification approach. Methods: Patients' renal outcome (≥50% decline in the estimated glomerular filtration rate or end-stage renal disease) in each subcohort was examined. Results: The number of prognostic factors identified in the multivariate Cox analysis was smaller in the "BMI ≥25, female" and CKD stage 3 subcohorts than in other subcohorts. Prognostic factors identified in the "BMI ≥25, CKD stage 3" subcohort only comprised albuminuria and male sex, and those in the "BMI ≥25, female" subcohort only comprised albuminuria, hyperphosphatemia, and anemia. Albuminuria, kidney impairment, male sex, hyperphosphatemia, anemia, and increased pulse pressure × heart rate product (PP × HR; pulsatile stress) were stable renal prognostic factors in almost all subcohorts. On the other hand, the prognostic value of increased BMI, younger age, hypoalbuminemia, increased intact parathyroid hormone, and decreased estimated 24-h urinary potassium excretion (e24hUK) differed according to subcohort. BMI was positively associated with CKD progression in the "BMI ≥25, age ≥65 years" and "BMI ≥25, CKD stages 4-5" subcohorts, whereas it was negatively associated with CKD progression in the "BMI < 25, diabetes mellitus" subcohort. PP × HR was independently associated with CKD progression in the "BMI < 25, CKD stage 3" subcohort, which had relatively few identified renal prognostic factors. Decreased e24hUK was a renal prognostic factor for CKD progression in the "BMI < 25, CKD stages 4-5" subcohort, while no significant factors were observed in the "BMI ≥25, CKD stages 4-5" subcohort. Conclusion: A BMI-based cross-classification approach, which provides more comprehensive findings than that in previous approaches, is expected to be an effective method for evaluating renal prognostic factors in patients with CKD who are affected by multiple risk factors.
Introduction
In clinical studies, subgroup analyses are not usually recommended because of the risk for false-positive or false-negative results. Furthermore, although conventional subgroup analyses commonly involve stratification analyses, which assess the influence of a single attribute, cross-classification analyses, which simultaneously assess the influence of multiple attributes, have rarely been reported. However, investigations utilizing a data disaggregation or cross-classification approach in medical settings with diverse patients can produce results closely reflecting the real clinical world.
Body mass index (BMI [kg/m 2 ]) has drawn attention as a prognostic factor for chronic kidney disease (CKD) [1] . However, the effect of excessive weight and obesity on CKD progression is controversial. Some studies on immunoglobulin A nephropathy have reported obesity as a predictor of CKD progression [2, 3] , while a recent study has reported that underweight status is a risk factor for renal function deterioration [4] . The hazard or OR for BMI as a renal prognostic factor adopts a J-shaped or U-shaped curve [5, 6] . Given this nonlinearity, it may be more effective to use BMI as an attribute-determination factor, rather than as a prognostic factor, in cross-classification analyses. The present study is the first to conduct a detailed investigation of the prognostic factors for CKD progression using a BMI-based crossclassification approach.
Materials and Methods

Study Design
This study utilized data from the CKD Japan Cohort study, a large-scale, multicenter, prospective, cohort study in Japan (UMIN clinical trial registry number: UMIN000020038) [7, 8] . The study protocol was approved by the Ethics Committee of each participating medical institution (Tokyo Women's Medical University: #1106). The study was conducted in accordance with the Declaration of Helsinki, 1975 Helsinki, (as revised in 2005 and in compliance with the current regulations. A total of 2,678 patients from 17 nephrology centers were enrolled, and the primary outcome was defined as a ≥50% decline in the estimated glomerular filtration rate (eGFR) relative to baseline or end-stage renal disease (ESRD). We initially examined the prognostic factors of CKD in the total cohort and subsequently divided the patients according to BMI (< 25 vs. ≥25). The final subcohorts were formed by multiplying each of 4 conventional attributes (age, sex, CKD stage, and diabetes mellitus [DM] ) with the BMI classification, which resulted in a total of 16 subcohorts for the investigation of CKD progression.
Inclusion Criteria
A total of 3,087 patients from 17 nephrology centers were recruited between April 2007 and March 2013. The following inclusion criteria were used at screening: (1) Japanese patients living in Japan; (2) age 20-75 years; and (3) a broad spectrum of CKD, defined as an eGFR of 10-59 mL/min/1.73 m 2 . The following patients were excluded from participation: (1) patients with polycystic kidney disease, human immunodeficiency virus infection, liver cirrhosis, active cancer, and patients who had received cancer treatment within
Data Collection
Measurement of Hemodynamic Parameters BP and HR were measured in outpatient clinics by using an automated sphygmomanometer after a 5-min rest. BP in the right arm was measured 3 times at intervals of 1 min, and the mean values were used for analyses. A mercury sphygmomanometer was used to measure the BP of patients who had frequent premature contractions, atrial fibrillation, or atrial flutter. Pulse pressure (PP) was calculated by subtracting diastolic BP from systolic BP.
Collection of Biological Samples and Measurements
Biological samples were collected annually and stored for the central laboratory. Whole blood, serum, and urine samples were collected for measurement of serum creatinine and cystatin C, HbA1c, intact parathyroid hormone (iPTH), and urinary albumin and creatinine levels. HbA1c was measured by the JDS method, and the value was converted to the A1C value measured by the NGSP method by adding 0.4% as determined by the Japanese Diabetes Society. Serum creatinine levels were measured enzymatically. Urine albumin and creatinine were assessed with the trypsin inhibitor activity and enzymatic methods, respectively. Urinary albumin excretion was expressed as the albumin to creatinine ratio (UACR). Total cholesterol concentrations were determined by an enzymatic method. Hemoglobin was measured by SLS-Hb method. The Tanaka formula [10] was used to estimate 24-h urinary sodium and potassium excretion from a casual urine specimen, taken at the baseline. Each clinical center measured serum creatinine at each visit. The correlations of serum creatinine concentrations measured at the respective clinical centers and central laboratories were examined, and the former concentrations corrected with the latter ones were used to address the interinstitutional heterogeneity of the data obtained. Furthermore, the functional relationship analysis estimating errors in the values measured at the respective clinical centers and central laboratories was conducted to make necessary corrections.
Definition of Comorbidities and Primary Causes of CKD
Hypertension was defined as systolic BP ≥140 mm Hg or diastolic BP ≥90 mm Hg or taking an antihypertensive agent. Hyperuricemia was defined as serum UA level ≥6.0 mg/dL or taking an antihyperuricemic agent. Hypercholesterolemia was defined as serum TC level ≥220 mg/dL or serum LDL level ≥140 mg/ dL or taking an antidyslipidemic agent. Hypoalphalipoproteinemia was defined as serum HDL level < 40 mg/ dL or taking an antidyslipidemic agent. Hypertriglyceridemia was defined as serum TG level ≥150 mg/dL or taking an antidyslipidemic agent. DM was defined as HbA1C ≥6.5%, a history of diagnosis with DM, or taking an antidiabetic agent. Diabetic nephropathy, chronic glomerulonephritis, and nephrosclerosis were defined by biopsy or clinical diagnosis by the doctor in charge.
Outcomes
The primary outcome was a composite renal outcome, which was defined as a ≥50% decline in eGFR from baseline or ESRD, which requires renal replacement therapy. A ≥50% decline in eGFR from baseline was detected at the first of 3 consecutive visits when the renal event occurred. Renal replacement therapy was defined as any of hemodialysis, peritoneal dialysis, or kidney transplantation.
Statistical Analysis
Continuous variables are reported as means ± SD or as medians (interquartile ranges); categorical variables are reported as percentages, unless otherwise stated. Group differences were evaluated using an analysis of variance, χ 2 -test, or Kruskal-Wallis test. To assess the primary endpoint, survival curves for 2 or 6 groups were plotted using the Kaplan-Meier method and evaluated using the log-rank test. Nonadjusted relationships between BMI and renal events were examined using Cox regression models with restricted cubic splines (knots were located at BMI values of 18.5, 23, 25, 27.5, and 30, and the reference point was a BMI of 22, in accordance with the WHO recommendations for Asian populations [11] ). Univariate Cox regression analyses were performed; variables with a p < 0.1 were selected for multivariate analyses. UACR was log-transformed. Multivariate Cox regression analyses using backward selection were performed (p value for exclusion, > 0.10) with multiple imputation using chained equations with predictive mean matching [12] . The number of imputations was 20, and the imputation model included the variables marked with an asterisk (*) in Table 1 , censoring indicators, and the Nelson-Aalen cumulative hazard estimator [13] . Interactions between BMI category and each predictor were considered by adding the BMI category and interaction term in the final model. Subgroup analyses were performed using the final model of the Cox regression analyses. Correlations between the identified prognostic predictors and other variables were assessed using the Pearson's correlation coefficient. Time-dependent receiver operating characteristics curves were estimated using the Kaplan-Meier estimator [14] . Calculated cutoff values minimized the distance from the point (sensitivity, 1 -specificity) = (0, 1) for the total cohort and all subcohorts. Sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, diagnostic OR [15] , and the area under the curve at 4 years were estimated, and a bootstrap method with 2,000 replications was used for 95% CI estimation. Two-sided p values < 0.05 were considered statistically significant. All analyses were performed using SAS statistical software version 9.4 (SAS Institute Inc., Cary, NC, USA).
Results
Patient Characteristics
The characteristics of the 2,678 patients at baseline are shown in Table 1 . The subjects consisted of 1,685 males and 993 females, and their mean age at baseline was 60.4 ± 11.5 years. As shown in Table 1 , the mean systolic blood pressure was 131.8 ± 18.6 mm Hg, diastolic blood pressure 76.2 ± 11.9 mm Hg, mean blood pressure was 94.7 ± 12.8 mm Hg, PP 55.6 ± 14.3 mm Hg, pulse pressure × heart rate product (PP × HR) 4 Proportions are based on nonmissing data. BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; MBP, mean blood pressure; PP, pulse pressure; HR, heart rate; PP x HR, pulse pressure x heart rate; CKD, chronic kidney disease; ALT, alanine aminotransferase; eGFR, estimated glomerular filtration rate; iPTH intact parathyroid hormone; LDL, low-density lipoprotein; HDL, high-density lipoprotein; UACR, urine albumin-to-creatinine ratio; e24hUK, estimated 24-h urinary potassium excretion; e24hUNa, estimated 24-h urinary sodium excretion; UCACR, urine calcium-to-creatinine ratio; UPCR, urine phosphorus-to-creatinine ratio; RASI, renin-angiotensin system inhibitor; ESA, erythropoiesis-stimulating agent; PWV, pulse wave velocity. a 
Predictive Characteristics of the Attributes
The predictive characteristics, including Kaplan-Meier survival curves and DORs, of the attributes used in the stratification and cross-classification analyses are illustrated in Increased BMI was associated with an increased risk of CKD progression in the range of BMI ≥25 (Fig. 1a) , which was observed in all subcohorts (Fig. 2b , c, 3a-d, 4a-c), with the exception of the subcohort of patients without DM (non-DM; Fig. 4d ). Furthermore, in the elderly (age ≥65 years) and female subcohorts, decreased BMI was also associated with an increased risk of CKD progression, resulting in U-shaped curves (Fig. 2c, Fig. 4b ). KaplanMeier curves based on BMI stratification for 6 BMI categories indicated that patients with 27.5≤ BMI < 30 had the poorest prognosis (Fig. 1b: log-rank, p = 0.0029). Kaplan-Meier curves based on BMI stratification for 2 BMI categories indicated that the renal survival rate of patients with BMI ≥25 was significantly lower than that for patients with BMI < 25 ( Fig. 2a : log-rank, p = 0.0003), which was observed in all subcohorts (Fig. 2d , e, 3e-h, 4e-g), with the exception of the elderly and non-DM subcohorts (Fig. 4h ).
The sex-based Kaplan-Meier survival curves indicated that the renal survival rate was significantly lower in male patients than in female patients ( Fig. 5a : log-rank, p < 0.0001), which was observed in the nonelderly (age < 65 years) and CKD stages 4-5 subcohorts ( (Fig. 6) .
The age-based Kaplan-Meier survival curves for the total cohort did not demonstrate a significant difference between elderly and nonelderly subcohorts (Fig. 7a , log-rank, p = 0.8). However, the renal survival rate of elderly patients was significantly lower than that for nonelderly patients in the "BMI < 25, non-DM" and "BMI < 25, female" subcohorts (log-rank; p = 0.002, p = 0.03, respectively; Fig. 7b ; in the online suppl. Appendix p 9: Appendix Fig. 3b , right top of the panel B). In contrast, the renal survival rate of elderly patients was significantly higher than that for nonelderly patients in the "BMI < 25, DM" and "BMI ≥25, CKD stages 4-5" subcohorts (log-rank; p = 0.0002, p < 0.05, respectively; Fig. 7c ; in the online suppl. Appendix p 9: Appendix Fig. 3B , right bottom of the panel A). The results for the DORs were similar (Fig. 8 ). Kaplan-Meier survival curves stratified by BMI (for 2 BMI categories in the total cohort) and age-based cubic spline curves according to BMI and Kaplan-Meier survival curves stratified by BMI. Kaplan-Meier survival curves stratified by BMI (2 BMI categories) are shown for the total cohort (a) and for age-based subcohorts (d, e). The cubic spline curves of the hazard ratio for renal outcomes according to BMI are shown for age-based subcohorts (b, c). Model-based 95% CIs are also reported (dashed lines). BMI, body mass index; eGFR, estimated glomerular filtration rate; 4 years, 4-year survival rate; HR, hazard ratio.
The CKD stage-based Kaplan-Meier survival curves indicated that the renal survival rate of patients with CKD stages 4-5 was significantly lower than that for patients with CKD stage 3 (in the online suppl. Appendix p 10: Appendix Fig. 3C-1 , log-rank, p < 0.0001), which was observed in all subcohorts (in the online suppl. Appendix pp 10, 11: Appendix Fig. 3C-1, 2) . The results for the DORs were similar (in the online suppl. Appendix p 13: Appendix Fig. 4) .
The DM-based Kaplan-Meier curves indicated that the renal survival rate of patients with DM was significantly lower than that of patients without DM (Fig. 9a , DM vs. non-DM, 60.7 vs. 75.5%; log-rank, p < 0.0001), which was observed in all subcohorts (Fig. 9b, d , e, in the online suppl. Appendix p 12: Appendix Fig. 3D) , with the exception of the "BMI < 25, age ≥65 years" subcohort ( Fig. 9c : DM vs. non-DM, 70.7 vs. 71.0%; log-rank, p = 0.9359). Similar results were obtained for the DORs (Fig. 10) . The Appendix provides the results for elderly nonobese patients with DM (in the online suppl. Appendix pp 4, 62-64: supplementary results, Appendix Table 4 ).
Primary Analyses
Results of the univariate and multivariate regression analyses (Cox hazards models) for associations between the evaluated variables and primary endpoint in the total cohort are shown in Table 2 .
The final model in the multivariate Cox analysis revealed the following risk factors as significantly associated with the primary endpoint: male sex; log UACR; increased phosphorus, PP × HR, BMI, and iPTH; and decreased e24hUK, hemoglobin, eGFR, age, and albumin (Table 2) . Interactions between BMI category and each predictor on the risk of CKD progression were not significant, with the exception of eGFR and e24hUK. Prespecified subgroup Cox analyses were performed for all subcohorts (Fig. 11-15 , in the online suppl. Appendix pp 68-71: Appendix Tables 6, 7 ). The number of prognostic factors identified in the multivariate Cox analysis was smaller in the "BMI ≥25, female" (Fig. 12 ) and CKD stage 3 subcohorts (Fig. 14) than in other subcohorts. Prognostic factors identified in the "BMI ≥25, CKD stage 3" subcohort only comprised log UACR and male sex (Fig. 14) , and those in the "BMI ≥25, female" subcohort only comprised log UACR, phosphorus, and hemoglobin (Fig. 12) .
As shown in Figures 11-15 , log UACR, eGFR, male sex, phosphorus, hemoglobin, and PP × HR were stable renal prognostic factors in almost all subcohorts. On the other hand, the prognostic value of BMI, age, serum albumin, iPTH, and e24hUK differed according to subcohort. PP × HR, which reflects pulsatile stress, was independently associated with CKD progression in most of subcohorts, including the "BMI < 25, CKD stage 3" subcohort (Fig. 14) . Reduced urinary potassium excretion was a limited renal prognostic factor for CKD progression in the "BMI < 25, CKD stages 4-5" subcohort, but not for the "BMI ≥25, CKD stages 4-5" subcohort (Fig. 14) . BMI was positively associated with CKD progression in the "BMI ≥25, age ≥65 years" and "BMI ≥25 (Fig. 13) , CKD stages 4-5" subcohorts ( Fig. 14) , whereas it was negatively associated with CKD progression in the "BMI < 25, DM" subcohort (Fig. 15) .
Characteristics of PP × HR
As PP × HR was a newly identified prognostic predictor of CKD progression, the correlations of PP × HR with other clinical and laboratory parameters at baseline were examined. As shown in Figure 16 , PP × HR was positively correlated with age (r = 0.22, p < 0.0001), UACR (r = 0.27, p < 0.0001), and PWV (r = 0.52, p < 0.0001). PP × HR was more positively correlated with age in females (r = 0.31) than in males (r = 0.16) in a stratified analysis with sex.
Supplementary Analyses
With consideration for accessibility in clinical settings, the prognostic predictors identified in the final Cox regression analyses model were dichotomized using cutoff values determined by time-receiver operating characteristics curves. The prognostic effects of CKD progression were confirmed using the DOR and Kaplan-Meier method for all cohorts (in the online suppl. Appendix pp 15-36, 72-76: Appendix Fig. 6-8 , Appendix Table 8 ; and Appendix pp 15-16, 37-40: Appendix Fig. 9 ).
Discussion
Recently, patient-centered medicine (PCM) has been advocated [16, 17] . For PCM, it is necessary to treat individual patients according to their heterogeneous characteristics [18] . The development of PCM requires patient-oriented research, focused on the individualization of results, disaggregation of data, and analysis of differences in subgroups [19] . Patients generally have many attributes, thus, previous studies using conventional subgroup analyses are limited, as classifications were based on a single variable (e.g., male vs. female, elderly vs. young) [16] . One-variable-at-a-time comparisons usually result in the subcohorts being more similar to the total cohort because patients simultaneously have multiple characteristics [20] , which was confirmed in our analyses as illustrated in the in the online supplementary Appendix (pp 7, 17-18: Appendix Fig. 2, 7 ). To overcome this limitation, we used cross classification, enabling effective classification using 2 attributes simultaneously. Subgroup analysis by cross classification allows the determination of positive and negative findings that identify which subcohort(s) will and will not benefit from a treatment intervention, respectively. In the future, research utilizing large datasets may become more popular, for which, cross-classification analysis will be highly useful. In the present study, the positive findings were that PP × HR is a prognostic factor in patients in the "BMI < 25, Table 5 is depicted. DORs of elderly patients (age ≥65 years) for a decline in eGFR by ≥50% from baseline or ESRD during the follow-up examination period are shown according to subcohort. BMI, body mass index; CKD, chronic kidney disease; DM, diabetes mellitus; DOR, diagnostic odd ratios. CKD stage 3" subcohort, and that e24hUK has importance for renal outcomes in patients in the "BMI < 25, CKD stages 4-5" subcohort in the multivariate Cox analyses, whereas the negative finding was that DM did not affect the renal prognosis in patients in the "BMI < 25, age ≥65 years" subcohort in the Kaplan-Meier analyses. Furthermore, as shown in the online supplementary results in the Appendix, we found differences in the cutoff values for renal anemia and hyperphosphatemia according to subcohort in the cross-classification analyses.
Conventional attributes, such as age, sex, CKD stage, and DM, have been reported as prognostic factors for renal outcomes. Many studies suggest that male sex is associated with worse renal outcomes [21] [22] [23] [24] , consistent with the present study ( Table 2 ). Sex differences exist in the pathogenesis and clinical prognosis of CKD [25] , and female sex seems to be renoprotective for the development and progression of CKD. Interestingly, in the Kaplan- Table 6 is depicted. The results of the multivariate Cox analysis for the prognostic predictors associated with a ≥50% eGFR decline or ESRD in subcohorts stratified by BMI are shown. BMI, body mass index; eGFR, estimated glomerular filtration rate; UACR, urine albumin-to-creatinine ratio; e24hUK, estimated 24-h urinary potassium excretion; PP × HR, pulse pressure × heart rate product; iPTH, intact parathyroid hormone; HR, hazard ratio. Table 5 is depicted. DORs of DM for a decline in eGFR by ≥50% from baseline or ESRD during the follow-up examination period are shown according to subcohort. BMI, body mass index; CKD, chronic kidney disease; DM, diabetes mellitus; DOR, diagnostic odd ratios. Table 7A is depicted. The results of the multivariate Cox analysis for the prognostic predictors associated with a ≥50% eGFR decline or ESRD in subcohorts cross classified by sex and BMI are shown. BMI, body mass index; eGFR, estimated glomerular filtration rate; 4-year, 4-year survival rate; UACR, urine albumin-to-creatinine ratio; e24hUK, estimated 24-h urinary potassium excretion; iPTH, intact parathyroid hormone; PP × HR, pulse pressure × heart rate product; HR, hazard ratio. Table 7B is depicted. The results of the multivariate Cox analysis for the prognostic predictors associated with a ≥50% eGFR decline or ESRD in subcohorts cross classified by age and BMI are shown. BMI, body mass index; eGFR, estimated glomerular filtration rate; 4-year, 4-year survival rate; UACR, urine albumin-to-creatinine ratio; PP × HR, pulse pressure × heart rate product; e24hUK, estimated 24-h urinary potassium excretion; HR, hazard ratio. Table 7C is depicted. The results of the multivariate Cox analysis for the prognostic predictors associated with a ≥50% eGFR decline or ESRD in the subcohorts cross classified by CKD stage and BMI are shown. BMI, body mass index; eGFR, estimated glomerular filtration rate; 4-year, 4-year survival rate; UACR, urine albumin-to-creatinine ratio; PP × HR, pulse pressure × heart rate product; e24hUK, estimated 24-h urinary potassium excretion; CKD, chronic kidney disease; HR, hazard ratio. Table 7D is depicted. The results of the multivariate Cox analysis for the prognostic predictors associated with a ≥50% eGFR decline or ESRD in the subcohorts cross classified by DM status and BMI are shown. BMI, body mass index; eGFR, estimated glomerular filtration rate; 4-year, 4-year survival rate; UACR, urine albumin-to-creatinine ratio; e24hUK, estimated 24-h urinary potassium excretion; PP × HR, pulse pressure × heart rate product; iPTH, intact parathyroid hormone; DM, diabetes mellitus; HR, hazard ratio.
The results of studies on elderly status as a prognostic factor for renal prognosis have been inconsistent [21] . In the present study, although elderly status was associated with slightly better renal outcomes in the total cohort (Table 2) , the prognostic characteristics of elderly patients in the Kaplan-Meier analyses differed according to the BMI-based cross-classified subcohort (Fig. 7b-e) . Considering that there may be pathophysiological differences between elderly and younger adult patients with CKD [26, 27] , it is reasonable to use age as an attribute in clinical studies.
Consistent with the present study results (Table 2 ), many studies suggest that decreased GFR is associated with worse renal outcomes [28] . Considering that reductions in GFR are associated with CKD complications that may lead to CKD progression, a subanalysis according to CKD stage is important and it is reasonable to use CKD stage as an attribute.
DM is generally considered a prognostic factor for the development and progression of CKD [21] . Although the total-cohort multivariate Cox analysis did not show significant differences in renal prognostic factors between patients with and without DM, the Kaplan-Meier analysis for the total cohort showed a significantly worse prognosis in terms of the 4-year renal survival rate in the patients with DM (Fig. 9a) . On the other hand, the Kaplan-Meier curves for the "BMI < 25, age ≥65 years" subcohort in both the DM and non-DM groups almost overlapped (Fig. 9c) . Although further investigation is needed, there is a possibility that DM does not affect the renal prognosis in nonoverweight elderly patients. Despite the high diabetes prevalence in the elderly population, evidence of treatment effects is deficient, especially regarding the lowering of glucose levels [29] . Our BMI-based cross-classification analysis indicated that the consideration of BMI might be useful in the treatment of elderly diabetic patients with CKD. Considering that DM in the elderly is metabolically different from DM in younger people [30] , DM can be reasonably used as an attribute for cross classification. Fig. 16 . Relationship between the double product of PP × HR with baseline variables. The analyses in relation to age were stratified by sex. BMI, body mass index; UACR, urine albumin-to-creatinine ratio; eGFR, estimated glomerular filtration rate; PWV, pulse wave velocity; ABI, ankle-brachial index; PP × HR, pulse pressure × heart rate product. , heart rate; PP x HR, pulse pressure x heart rate; iPTH, intact parathyroid hormone; UACR, urine albumin-to-creatinine ratio; ALT, alanine aminotransferase; HDL, high-density lipoprotein; LDL, low-density lipoprotein; UCACR, urine calcium-to-creatinine ratio; UPCR, urine phosphorus-to-creatinine ratio; e24hUNa, estimated 24-h urinary sodium excretion; e24hUK, estimated 24-h urinary potassium excretion; MBP, mean blood pressure.
In the present study, we investigated many clinical factors, including urinary electrolytes, to identify potentially new renal prognostic factors using multivariate Cox regression analysis (Table 2) .
Among the identified prognostic factors in the present study, albuminuria [31] , kidney impairment [24, [31] [32] [33] [34] , male sex [21] [22] [23] [24] [34] [35] [36] , hyperphosphatemia [37] [38] [39] [40] [41] [42] , anemia [31, 32, 37, 43, 44] , hypoalbuminemia [31] , overweight/obesity [45, 46] , younger age [32, 34] , increased iPTH [47] , and decreased urinary potassium excretion [48] [49] [50] have been previously reported as renal prognostic factors for CKD [21, 51, 52] . However, there are no reports using a BMI-based cross-classification approach for the assessment of prognostic factors. The present study provides additional findings regarding previous prognostic factors by using BMI-based cross classification. Although albuminuria, kidney impairment, male sex, hyperphosphatemia, anemia, and PP × HR were stable renal prognostic factors in almost all subcohorts, the prognostic value of having overweight/obese status, younger age, hypoalbuminemia, increased iPTH, and decreased urinary potassium excretion differed according to subcohort. Among these identified prognostic factors, the present study is the first to show that PP × HR (pulsatile stress) is a prognostic factor for CKD progression. Furthermore, we found that decreased urinary potassium excretion is a risk factor for CKD progression in patients with both BMI < 25 and CKD stages 4-5.
PP × HR was independently associated with CKD progression, not only in the total cohort but also in many subcohorts. Especially, these results are clinically important for the "BMI < 25, CKD stage 3" subcohort ( Fig. 14a) , as the number of identified renal prognostic factors was less for this subcohort. Recently, PP was found to be associated with CKD progression for all CKD stages [53] . In a review by Safar [54] , PP × HR was said to be significant, in that HR has more substantial links with PP than with mean blood pressure; an increase in PP × HR, more than PP itself, might cause vascular wall fatigue, particularly in the presence of atherosclerosis. Furthermore, PP × HR is associated with a higher risk of albuminuria in renal transplant recipients [55] . Although further investigation is needed, PP × HR is expected to receive more attention as an important parameter in clinical settings.
The current results may have broader worldwide implications for patients with various diseases. The BMI-based cross-classification analysis performed in the present study is consistent with treatment according to the patient's body size in Oriental medicine, suggesting a link between Oriental and Western medicine. The present study's strengths lie in the detailed analyses, designed to disaggregate data using BMI-based cross classification, which is significant to achieving PCM. We found differences in the predictive characteristics and cutoff values of several risk factors for predicting renal outcomes, via an analysis of crossclassified subcohorts. Despite these strengths, our study had several limitations. First, the patient characteristics were determined only at baseline, and data during the follow-up period were not considered. Second, the study was observational in nature; thus, any observed associations do not prove causality. Third, all of the patients in the present study were outpatients under nephrology care at major regional medical institutions; thus, a selection bias cannot be ruled out. Fourth, we did not investigate dietary factors, which may influence urinary potassium excretion. Fifth, the sample size was relatively small for a cross-classification analysis and prevented us from performing cross-classification analyses using > 2 attributes simultaneously. Further studies are needed to confirm our findings in a larger cohort.
Conclusion
A BMI-based cross-classification approach, which provides more comprehensive findings than that in previous approaches, is expected to be an effective method for evaluating patients with CKD who are affected by multiple risk factors.
